Here’s a quick look at what you found most interesting during the past year.
ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin
Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations
Putting Patients First: Breaking Stigma, Dispelling Misconceptions to Improve IBS Care
Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
Study Investigates Optimal COVID-19 Vaccination Timing in Inflammatory Disease
GPT-4 Nears 'Expert-Level' Performance in Ophthalmology Examination
